MultiVitamin
Natural health product licensed in Canada
- Licence holder
- Supp Buddy
- NPN or DIN-HM
- 80085381
- Status
- Active licence
- Licence date
- 18 May 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine E: up to 34 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 30 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 8.325 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 34 mg | 34,000 µg |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 25 UI | Not calculated |
| Cuivre Source : Citrate de cuivre (II) | 500 mcg | 500 µg |
| Molybdène Source : Citrate de molybdène (VI) | 15 mcg | 15 µg |
| Vitamine D Source : Cholécalciférol | 333 UI | 8.325 µg |
| Manganèse Source : Citrate de manganèse (II) | 1 mg | 1,000 µg |
| Vitamine K2 Source : Ménaquinone 7 | 90 mcg | 90 µg |
| Thiamine Source : Thiamine | 25 mg | 25,000 µg |
| Riboflavine Source : Riboflavine | 15 mg | 15,000 µg |
| Niacinamide Source : Niacinamide | 15 mg | Not calculated |
| Vitamine B6 Source : Pyridoxine 5-phosphate | 15 mg | 15,000 µg |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 333 mcg | Not calculated |
| Vitamine B12 Source : L-5 Méthyltétrahydrofolate, sel de calcium | 333 mcg | 333 µg |
| Calcium Source : Citrate de calcium | 100 mg | 100,000 µg |
| Magnésium Source : Bisglycinate de magnésium | 50 mg | 50,000 µg |
| Zinc Source : Citrate de zinc | 5 mg | 5,000 µg |
| Iode Source : Iodure de potassium | 50 mcg | 50 µg |
| Sélénium Source : Sélénométhionine | 20 mcg | 20 µg |
| Biotine Source : Biotine | 75 mcg | 75 µg |
| Vitamine D Source : Cholécalciférol | 8 mcg | 8 µg |
Non-medicinal ingredients
Dioxyde de silicium, Pullulane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones and teeth. Helps in wound healing. Helps in connective tissue formation. Source of/An antioxidant that protects the fat in body tissues from oxidation. Helps in the development and maintenance of bones. Helps in energy production. Helps normal growth and development. Helps to maintain the body's ability to metabolize nutrients. Helps to form red blood cells. Helps in the normal function of the immune system. Helps to maintain cognitive functions. Helps in the process of normal regulation of cell division and specialization. Source of/An electrolyte for the maintenance of good health. Helps to maintain normal muscle function. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Helps to maintain proper muscle function, including the heart muscle. Helps to maintain healthy skin. Helps to maintain normal DNA synthesis. Helps to produce and repair connective tissue. Helps to maintain normal iron transport in the body. Helps to maintain normal production of thyroid hormones. Source of/An antioxidant that helps (to) protect (cells) against (the oxidative effect of cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085381
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.